首页> 美国卫生研究院文献>Applied and Environmental Microbiology >Induction of Immune Responses in Mice after Intragastric Administration of Lactobacillus casei Producing Porcine Parvovirus VP2 Protein
【2h】

Induction of Immune Responses in Mice after Intragastric Administration of Lactobacillus casei Producing Porcine Parvovirus VP2 Protein

机译:胃内给药产生猪细小病毒VP2蛋白的干酪乳杆菌胃内给药后小鼠的免疫应答诱导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lactobacillus casei ATCC 393 was selected as an antigen delivery vehicle for mucosal immunization against porcine parvovirus (PPV) infection. A 64-kDa fragment of PPV major protective antigen VP2 protein was used as the parvovirus antigen model. A recombinant Lactobacillus expressing VP2 protein was constructed with plasmid pPG611.1, where expression and localization of the VP2 protein from recombinant Lc393-rPPV-VP2 was detected via sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blotting, and immunofluorescence. Both local mucosal and systemic immune responses against PPV were induced in BALB/c mice immunized orally with the recombinant Lactobacillus expressing VP2 protein. The induced antibodies demonstrated neutralizing effects on PPV infection. These data indicated that the use of recombinant lactobacilli could be a valuable strategy for future vaccine development of PPV.
机译:选择干酪乳杆菌ATCC 393作为针对猪细小病毒(PPV)感染的粘膜免疫的抗原递送载体。 PPV主要保护性抗原VP2蛋白的64 kDa片段用作细小病毒抗原模型。用质粒pPG611.1构建表达VP2蛋白的重组乳杆菌,其中重组Lc393-rPPV-VP2中VP2蛋白的表达和定位通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳,蛋白质印迹和免疫荧光检测。在用表达VP2蛋白的重组乳杆菌口服免疫的BALB / c小鼠中,诱导了针对PPV的局部粘膜和全身免疫反应。诱导的抗体对PPV感染表现出中和作用。这些数据表明,重组乳杆菌的使用可能是PPV未来疫苗开发的有价值的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号